A Pilot Study of Brentuximab Vedotin Combined With AVD Chemotherapy in Patients With Newly Diagnosed Early Stage, Unfavorable Risk Hodgkin Lymphoma
Phase of Trial: Phase II
Latest Information Update: 01 Mar 2018
At a glance
- Drugs Brentuximab vedotin (Primary) ; Dacarbazine; Doxorubicin; Vinblastine
- Indications Hodgkin's disease
- Focus Adverse reactions; Therapeutic Use
- 26 Feb 2018 Planned End Date changed from 1 May 2018 to 1 May 2019.
- 26 Feb 2018 Planned primary completion date changed from 1 May 2018 to 1 May 2019.
- 12 Dec 2017 Results (n=29) of cohort 2 of study, were presented at the 59th Annual Meeting and Exposition of the American Society of Hematology.